US equities |
NVDA $204.64 ▼-4.22% INTC $65.76 ▼-28.58% MU $884.74 ▼-5.30% AMZN $240.35 ▼-1.41% AAPL $344.63 ▼-1.23% SNDK $1,150.89 ▼-13.47% AMD $504.80 ▼-10.88% MSFT $521.91 ▼-1.55%
FinancialContent

Dermata Therapeutics, Inc. - Common Stock (NQ:DRMA)

0.7750 -0.0650 (-7.74%)
Delayed Quote Updated: 4:00 PM EDT, Oct 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dermata Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
News headline image
Dermata Advances Second Tome Skincare Product Toward Expected 2027 Launch with Initiation of Acne Clinical Trial
- Tome Clearing Treatment is Dermata's second once-weekly skincare product under its Tome brand - - Tome Clearing Treatment includes a salicylic acid wipe with Dermata's Bioneedle ™ mask and is... 
From Dermata Therapeutics
Via ACCESS Newswire
News headline image
Stocks to Watch: WETO, PRSO, DRMA, SNES Highlight Robotics, Defense, Skincare and Revenue Growth
Via AB Newswire
Topics Artificial Intelligence
News headline image
Graphene Manufacturing (OTCQX: GMGMF) Reports Battery Energy Density Gains
Via AB Newswire
Topics Artificial Intelligence
Which stocks are most active on Thursday? ↗
Via Chartmill
Dermata Therapeutics (NASDAQ:DRMA) Q1 2026 Earnings: Narrowing Losses and Strategic Pivot to DTC Skincare ↗
Via Chartmill
Top stock movements in today's session. ↗
Via Chartmill
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
Via Chartmill
News headline image
Dermata Therapeutics Announces Positive Topline Results from Cosmetic Study Evaluating Its Tome Foundational Treatment
- Once-weekly Tome Foundational Treatment demonstrated improvements across key measures of skin appearance after four treatments - - Over 71% of study participants were graded as having overall... 
From Dermata Therapeutics
Via ACCESS Newswire
News headline image
Dermata Therapeutics Announces Commercial Launch of Tome Foundational Treatment
From Dermata Therapeutics
Via ACCESS Newswire
News headline image
Dermata Announces Preorders Now Open for Tome Foundational Treatment Ahead of Commercial Launch
From Dermata Therapeutics
Via ACCESS Newswire
News headline image
Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
From Dermata Therapeutics
Via ACCESS Newswire
Unusual volume stocks are being observed in Wednesday's session. ↗
Via Chartmill
The market is filled with gapping stocks in Wednesday's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers Dermata Therapeutics (NASDAQ:DRMA) stock moved upwards by 44.4% to $1.56 during Tuesday's after-market session. The company's market cap stands at $4.5 million. As per the news, the Q2 earnings... 
Via Benzinga
News headline image
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026
From Dermata Therapeutics
Via ACCESS Newswire
News headline image
Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment
From Dermata Therapeutics
Via ACCESS Newswire
News headline image
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026
Via ACCESS Newswire
News headline image
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System
Via ACCESS Newswire
News headline image
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025
Via ACCESS Newswire
What's going on in today's session ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
Get insights into the top gainers and losers of Thursday's after-hours session. ↗
Via Chartmill
News headline image
Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing
Via ACCESS Newswire
News headline image
Dermata Opens a New Chapter with the Release of Tome Skincare
Via ACCESS Newswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Top movers in Friday's session ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
Which stocks are moving before the opening bell on Friday? ↗
Via Chartmill
Top stock movements in today's session. ↗
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >